...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO Investor Forum, Oct 22-23

,,I called in to Zenith and was put thru to Sara who was not there,,a message was left asking her to call back,!

Share
New Message
Please login to post a reply